Oppenheimer & CO Inc Gsk PLC Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$42.05 - $47.77 $1.86 Million - $2.12 Million	44,293 Added 41.5%	151,027 $6.57 Million
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $157,621 - $187,045	3,918 Added 3.81%	106,734 $4.65 Million
Q4 2021 Feb 02, 2022	SELL	$38.88 - $45.31 $313,956 - $365,878	-8,075 Reduced 7.28%	102,816 $4.53 Million
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $137,937 - $153,476	3,556 Added 3.31%	110,891 $4.24 Million
Q2 2021 Aug 03, 2021	BUY	$36.52 - $41.46 $121,355 - $137,771	3,323 Added 3.19%	107,335 $4.27 Million
Q1 2021 May 10, 2021	BUY	$34.27 - $40.01 $273,268 - $319,039	7,974 Added 8.3%	104,012 $3.71 Million
Q4 2020 Feb 11, 2021	SELL	$34.07 - $39.94 $131,612 - $154,288	-3,863 Reduced 3.87%	96,038 $3.53 Million
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $85,137 - $96,039	-2,234 Reduced 2.19%	99,901 $3.76 Million
Q2 2020 Aug 11, 2020	BUY	$37.87 - $43.58 $731,004 - $841,224	19,303 Added 23.3%	102,135 $4.17 Million
Q1 2020 May 08, 2020	BUY	$32.47 - $48.83 $299,016 - $449,675	9,209 Added 12.51%	82,832 $3.14 Million
Q4 2019 Feb 07, 2020	BUY	$42.0 - $48.25 $111,594 - $128,200	2,657 Added 3.74%	73,623 $3.46 Million
Q3 2019 Oct 31, 2019	SELL	$40.46 - $43.52 $49,725 - $53,486	-1,229 Reduced 1.7%	70,966 $3.03 Million
Q2 2019 Aug 09, 2019	SELL	$39.4 - $42.7 $447,071 - $484,516	-11,347 Reduced 13.58%	72,195 $2.89 Million
Q1 2019 Apr 24, 2019	SELL	$38.57 - $42.69 $11,725 - $12,977	-304 Reduced 0.36%	83,542 $3.49 Million
Q4 2018 Jan 29, 2019	SELL	$37.8 - $42.69 $680,022 - $767,993	-17,990 Reduced 17.67%	83,846 $3.2 Million
Q3 2018 Oct 26, 2018	SELL	$39.75 - $42.69 $40,704 - $43,714	-1,024 Reduced 1.0%	101,836 $4.09 Million
Q2 2018 Aug 10, 2018	SELL	$39.61 - $42.76 $561,669 - $606,336	-14,180 Reduced 12.12%	102,860 $4.15 Million
Q1 2018 May 01, 2018	BUY	$36.18 - $40.15 $1.53 Million - $1.7 Million	42,238 Added 56.47%	117,040 $4.57 Million
Q4 2017 Feb 07, 2018	SELL	$35.34 - $41.9 $625,129 - $741,169	-17,689 Reduced 19.13%	74,802 $2.65 Million
Q3 2017 Nov 09, 2017	BUY	$39.44 - $41.55 $3.65 Million - $3.84 Million	92,491	92,491 $3.76 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account